Application 021993
- Type
- NDA
- Sponsor
- BAYER HEALTHCARE LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLARITIN REDITABS | LORATADINE | TABLET, ORALLY DISINTEGRATING;ORAL | 5MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021993-001 | CLARITIN REDITABS | LORATADINE | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Claritin Reditabs | LORATADINE | Bayer HealthCare LLC | 7dc04b48-f053-4e4b-a493-9e8286d2a791 | 2025-12-05 | Warnings | 021993 NDA021993 11523-7202 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 11523-7202 | Claritin | Loratadine | Bayer HealthCare LLC | NDA | Current |
| 11523-7202 | Claritin | Loratadine | Bayer HealthCare LLC | NDA | Current |
| 11523-7202 | Claritin | Loratadine | Bayer HealthCare LLC | NDA | Current |
| 11523-7202 | Claritin | Loratadine | Bayer HealthCare LLC | NDA | Current |
| 11523-7202 | Claritin | Loratadine | Bayer HealthCare LLC | NDA | Current |
| 11523-7202 | Claritin | Loratadine | Bayer HealthCare LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 74407 | SUPPL | 2023-05-30 |
| 74377 | SUPPL | 2023-05-26 |
| 57867 | SUPPL | 2019-03-01 |
| 57857 | SUPPL | 2019-03-01 |
| 55107 | SUPPL | 2018-08-03 |
| 54971 | SUPPL | 2018-07-25 |
| 38030 | SUPPL | 2015-12-01 |
| 29007 | SUPPL | 2015-11-27 |
| 38029 | SUPPL | 2014-07-29 |
| 6625 | SUPPL | 2014-07-24 |
| 6624 | SUPPL | 2008-10-23 |
| 42372 | ORIG | 2008-10-03 |
| 38028 | ORIG | 2006-12-14 |
| 29006 | ORIG | 2006-12-14 |